Advent closes life sciences fund on $125m

Advent International has announced a $125m final close on its third healthcare and life sciences early stage vehicle.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this